Search - tctmd.com

Displaying 1 - 20 of 55

Sort: Relevancy | Date

Presentation TCT 2022

Discussion - What does this Field Need Next?

Presenter: Felix Mahfoud

September 19, 2022

Presentation TCT 2022

Who Should be Treated with uRDN?

Presenter: Naomi Fisher

September 19, 2022

Presentation TCT 2022

Discussion - Key Takeaways from the RADIANCE Clinical Program

Presenter: Felix Mahfoud

September 19, 2022

Presentation TCT 2022

Late-Breaking Evidence from RADIANCE II

Presenter: Michel Azizi

September 19, 2022

Presentation TCT 2022

Introduction and Objectives

Presenter: Felix Mahfoud

September 19, 2022

Presentation TCT 2022

FLASH 800 and clinical implications

Presenter: Catalin Toma

September 19, 2022

Presentation TCT 2022

Why intervene in submassive patients

Presenter: Wissam Jaber

September 19, 2022

Presentation TCT 2022

FlowTriever in high-risk patients

Presenter: Sanjum Sethi

September 19, 2022

Presentation TCT 2022

Introduction to the PE/VTE landscape and critical unmet needs

Presenter: Shon Chakrabarti

September 19, 2022

EMPOWER Trail Design & Patient Selection

Presentation TCT 2022

EMPOWER Trial Design & Patient Selection

Presenter: Samir Kapadia

September 19, 2022

Presentation TCT 2022

Application & Carillon Procedure (Recorded Case Moderation)

Presenter: Murat Yildiz

September 19, 2022

Presentation TCT 2022

CINCH-FMR Post-Market Registry Interim Results

Presenter: Klaus Witte

September 19, 2022

Presentation TCT 2022

Annular Reduction Therapy For Heart Failure

Presenter: Nabil Dib

September 19, 2022

Presentation TCT 2022

Next Generation Repair Technologies in the Mitral Field – Annuloplasty and Chordal Replacement

Presenter: Azeem Latib

September 18, 2022

Presentation TCT 2022

The Argument for a TEER Trial in the FMR Space – CLASP IIF

Presenter: Brian Whisenant

September 18, 2022

Presentation TCT 2022

Echo Sees All – so what can we learn from echo in the CLASP Trials?

Presenter: Linda Gillam

September 18, 2022

Presentation TCT 2022

Insights from the CLASP IID Registry

Presenter: Jörg Hausleiter

September 18, 2022

Presentation TCT 2022

TEER in Evolution – PASCAL in DMR; insights on data from CLASP IID RCT

Presenter: Scott Lim

September 18, 2022

Presentation TCT 2022

Results and benefits of aortic intervention in the US by age.

Presenter: Megan Coylewright

September 18, 2022

Presentation TCT 2022

Considerations of TAVR and SAVR by age in the US including a clinically relevant definition of Bioprosthetic Durability

Presenter: Evelio Rodriguez

September 18, 2022

Advertisement

Discussion - What does this Field Need Next?

Who Should be Treated with uRDN?

Discussion - Key Takeaways from the RADIANCE Clinical Program

Late-Breaking Evidence from RADIANCE II

Introduction and Objectives

FLASH 800 and clinical implications

Why intervene in submassive patients

FlowTriever in high-risk patients

Introduction to the PE/VTE landscape and critical unmet needs

EMPOWER Trial Design & Patient Selection

Application & Carillon Procedure (Recorded Case Moderation)

CINCH-FMR Post-Market Registry Interim Results

Annular Reduction Therapy For Heart Failure

Next Generation Repair Technologies in the Mitral Field – Annuloplasty and Chordal Replacement

The Argument for a TEER Trial in the FMR Space – CLASP IIF

Echo Sees All – so what can we learn from echo in the CLASP Trials?

Insights from the CLASP IID Registry

TEER in Evolution – PASCAL in DMR; insights on data from CLASP IID RCT

Results and benefits of aortic intervention in the US by age.

Considerations of TAVR and SAVR by age in the US including a clinically relevant definition of Bioprosthetic Durability

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content